• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

性别重置手术后用于治疗尿失禁的尿道周围胶原蛋白。

Periurethral collagen for urinary incontinence after gender reassignment surgery.

作者信息

Fitzpatrick C, Swierzewski S J, McGuire E J

机构信息

Department of Surgery, University of Michigan Medical Center, Ann Arbor.

出版信息

Urology. 1993 Oct;42(4):458-60. doi: 10.1016/0090-4295(93)90388-q.

DOI:10.1016/0090-4295(93)90388-q
PMID:8212451
Abstract

We report on 2 patients, one female and one male transsexual; in both, Type III stress urinary incontinence developed after gender reassignment surgery. Both patients were treated by periurethral injection of gluteraldehyde cross-linked collagen resulting in a marked symptomatic improvement in association with a significant rise in abdominal leak point pressures. We believe these are the first reported cases of collagen injection being used for urinary incontinence after gender reassignment surgery.

摘要

我们报告了2例患者,1例为女性变性者,1例为男性变性者;两人在性别重置手术后均出现了III型压力性尿失禁。两名患者均接受了经尿道注射戊二醛交联胶原蛋白治疗,症状明显改善,同时腹压漏尿点压力显著升高。我们认为这是首次报道将胶原蛋白注射用于性别重置手术后尿失禁治疗的病例。

相似文献

1
Periurethral collagen for urinary incontinence after gender reassignment surgery.性别重置手术后用于治疗尿失禁的尿道周围胶原蛋白。
Urology. 1993 Oct;42(4):458-60. doi: 10.1016/0090-4295(93)90388-q.
2
Periurethral collagen injection for male and female sphincteric incontinence: indications, techniques, and result.用于男性和女性括约肌性尿失禁的尿道周围胶原注射:适应证、技术及结果
World J Urol. 1997;15(5):306-9. doi: 10.1007/BF02202016.
3
[Female stress urinary incontinence. Treatment with collagen infiltration in the urethra].[女性压力性尿失禁。尿道胶原注入治疗]
Arch Esp Urol. 1997 Jul-Aug;50(6):655-9.
4
Periurethral injection therapy for urinary incontinence in women.女性尿失禁的尿道周围注射疗法
Cochrane Database Syst Rev. 2007 Jul 18(3):CD003881. doi: 10.1002/14651858.CD003881.pub2.
5
Periurethral injection therapy for urinary incontinence in women.女性尿失禁的尿道周围注射疗法
Cochrane Database Syst Rev. 2003(2):CD003881. doi: 10.1002/14651858.CD003881.
6
Complications of periurethral collagen injection for stress urinary incontinence.用于治疗压力性尿失禁的尿道周围胶原蛋白注射的并发症。
J Urol. 1998 Mar;159(3):806-7.
7
Treatment of stress urinary incontinence in women with urethral hypermobility and intrinsic sphincter deficiency.治疗伴有尿道活动过度和固有括约肌功能不全的女性压力性尿失禁。
J Urol. 1996 Dec;156(6):1995-8.
8
[Efficacy of periurethral injections of polyacrylamide hydrogel (Bulkamid(®)) and quality of life of patients with urinary incontinence due to sphincter deficiency (IUE-IS)].[聚丙稀酰胺水凝胶(Bulkamid®)尿道周围注射治疗括约肌功能不全所致尿失禁(IUE-IS)的疗效及患者生活质量]
Prog Urol. 2014 Jun;24(8):501-10. doi: 10.1016/j.purol.2014.02.003. Epub 2014 Mar 22.
9
Clinical and urodynamic evaluation in women with stress urinary incontinence treated by periurethral collagen injection.经尿道周围胶原注射治疗压力性尿失禁女性的临床和尿动力学评估
Int Braz J Urol. 2007 Sep-Oct;33(5):695-702; discussion 702-3. doi: 10.1590/s1677-55382007000500012.
10
Periurethral injection of collagen in the treatment of urinary stress incontinence: ultrasonographic appearance.
Can Assoc Radiol J. 1995 Jun;46(3):189-93.

引用本文的文献

1
Urinary symptoms after genital gender-affirming penile construction, urethral lengthening and vaginectomy.生殖器性别确认阴茎再造、尿道延长和阴道切除术后的泌尿系统症状。
Transl Androl Urol. 2023 May 31;12(5):932-943. doi: 10.21037/tau-22-675. Epub 2023 Mar 1.
2
Lower Urinary Tract Symptoms in Male-to-Female Transsexuals: Short Terms Results and Proposal of a New Questionnaire.男变女跨性别者的下尿路症状:短期结果及一份新问卷的提议
Plast Reconstr Surg Glob Open. 2016 Mar 18;4(3):e655. doi: 10.1097/GOX.0000000000000635. eCollection 2016 Mar.
3
Stress urinary incontinence after male to female gender reassignment surgery: Successful use of a pubo-vaginal sling.
男性变女性性别重置手术后的压力性尿失禁:耻骨阴道吊带的成功应用
Indian J Urol. 2007 Jul;23(3):311-3. doi: 10.4103/0970-1591.33731.